Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
T.PoojariP
Harries M
While the patient groups did not differ by sex, M/M were of slightly lower age relative to both HC and SA and, unsurprisingly, higher fractional exhaled nitric oxide (FeNO) and lower FEV 1 (% predicted) were observed across groups from HC to SA
US$ 29.70
US$ 22.57
US$ 26.85
US$ 28.96
US$ 20.75
US$ 27.03
US$ 24.71
US$ 25.45
US$ 20.60
US$ 21.09
US$ 25.81
